Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in the past ...

Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...

On Wednesday, Sanofi SA (SNY) stock saw a decline, ending the day at $49.23 which represents a decrease of $-0.64 or -1.28% from the prior close of $49.87. The stock opened at $49.13 and touched a low ...

Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in ...

HB Wealth Management LLC increased its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 151.8% in the fourth ...

Looking into the current session, Sanofi Inc. SNY shares are trading at $49.35, after a 0.24% increase. Moreover, over the ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

What has been 52-week high of Sanofi India Ltd stocks? The highest price of Sanofi India Ltd stock is ₹10,524.95 in the last 52-week. What is the share price of Sanofi India Ltd (SANOFI ...

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...

Compared to the aggregate P/E ratio of the 27.1 in the Pharmaceuticals industry, Sanofi Inc ... It's also possible that the stock is undervalued. In conclusion, the price-to-earnings ratio ...